Who Paid My Doc
-Ph III MASH pivotal trials
Research payments
$105,708
Through program year 2025, $105,708 in research payments was reported against -Ph III MASH pivotal trials, across 76 payments, paid by Boehringer Ingelheim International GmbH.
- Paid by
- Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $5,689 | 33 |
| 2024 | Research | $100,020 | 43 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Bradley Vander Veen Clarksville, TN Named on 14 payments
- Shilpi Mittal Forney, TX Named on 7 payments
- Richard Mohammed Port Orange, FL Named on 5 payments
- Sureka Bollepalli Tampa, FL Named on 5 payments
- Richard Manch Glendale, AZ Named on 5 payments
- Ronald Fogel Chesterfield, MI Named on 2 payments
- Mazen Noureddin Houston, TX Named on 2 payments
- Humberto Aguilar Shreveport, LA Named on 2 payments
- Shannon Bauman West Des Moines, IA Named on 2 payments
- Stephen Miller Boston, MA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.